Cargando…

Individualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice

PURPOSE: This postmarketing surveillance survey was conducted to investigate the utility of the CONsistency in r-FSH Starting dOses for individualized tReatmenT (CONSORT) calculator for individualizing recombinant human follicle-stimulating hormone (r-hFSH) starting doses for controlled ovarian stim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naether, Olaf GJ, Tandler-Schneider, Andreas, Bilger, Wilma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403744/ https://www.ncbi.nlm.nih.gov/pubmed/25926756 http://dx.doi.org/10.2147/DHPS.S77320

Ejemplares similares

A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
por: Bühler, Klaus, et al.
Publicado: (2014)

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
por: Nawroth, Frank, et al.
Publicado: (2015)

Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
por: Hussain, Munawar, et al.
Publicado: (2013)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
por: Bühler, Klaus F., et al.
Publicado: (2021)

Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017)
por: Fatemi, Human, et al.
Publicado: (2021)

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
por: Yang, Chunxia, et al.
Publicado: (2022)

A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study
por: Bühler, Klaus, et al.
Publicado: (2011)

Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction
por: Park, Hyo Young, et al.
Publicado: (2015)

CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
por: Kwakkenbos, Linda, et al.
Publicado: (2021)

Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction
por: Himabindu, Y, et al.
Publicado: (2013)

Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
por: Welcker, J Thomas, et al.
Publicado: (2010)

IJD(®): Consorting with CONSORT 2010
por: Panda, Saumya, et al.
Publicado: (2013)

Associations of reproductive factors with postmenopausal follicle stimulating hormone
por: Costa, Rebecca, et al.
Publicado: (2022)

Protocol of the CONSORT and SPIRIT Extension for multicenter clinical trials
por: Zhang, Xuan, et al.
Publicado: (2023)

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2014)

Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)
por: Imran, Mahrukh, et al.
Publicado: (2021)

Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
por: Illingworth, Peter J, et al.
Publicado: (2014)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
por: Zhao, Shen, et al.
Publicado: (2023)

Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)
por: Strowitzki, Thomas, et al.
Publicado: (2016)

Consort music
por: Dowland, John, 1563?-1626
Publicado: (1987)

The CONSORT statement
por: Cuschieri, Sarah
Publicado: (2019)

Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
por: Nahuis, Marleen, et al.
Publicado: (2010)

Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level
por: Safdarian, Leili, et al.
Publicado: (2012)

Interrelationships among reproductive hormones and antral follicle count in human menstrual cycles
por: Robertson, David Mark, et al.
Publicado: (2016)

Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data
por: Kwakkenbos, Linda, et al.
Publicado: (2018)

Long-acting recombinant human follicle-stimulating hormone (SAFA-FSH) enhances spermatogenesis
por: Kim, Daham, et al.
Publicado: (2023)

Genetically Determined Dosage of Follicle-Stimulating Hormone (FSH) Affects Male Reproductive Parameters
por: Grigorova, Marina, et al.
Publicado: (2011)

Late consort music
por: Jenkins, John, 1592-1678
Publicado: (1992)

Consort music and songs
por: Dowland, John, 1563-1626
Publicado: (1997)

Consort Music and Songs/
por: Dowland, John

The role of growth hormone in assisted reproduction
por: Quaas, Alexander M., et al.
Publicado: (2022)

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2010)

Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study
por: Strowitzki, Thomas, et al.
Publicado: (2016)

Hormonal Effects on Hair Follicles
por: Grymowicz, Monika, et al.
Publicado: (2020)

Effectiveness of a recombinant human follicle stimulating hormone on the ovarian follicles, peripheral progesterone, estradiol-17β, and pregnancy rate of dairy cows
por: Ali, Mohamed, et al.
Publicado: (2016)

Corticosterone metabolism by chicken follicle cells does not affect ovarian reproductive hormone synthesis in vitro
por: Rettenbacher, Sophie, et al.
Publicado: (2013)

Overview of follicle stimulating hormone and its receptors in reproduction and in stem cells and cancer stem cells
por: Haldar, Swati, et al.
Publicado: (2022)

A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study
por: Choi, Bum Chae, et al.
Publicado: (2022)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gp6sid02isca54btn4vkh7lhco